Davide Tinti

ORCID: 0000-0002-7265-9360
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Management and Research
  • Diabetes and associated disorders
  • Pancreatic function and diabetes
  • Diabetes Treatment and Management
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • COVID-19 Clinical Research Studies
  • Cardiovascular Function and Risk Factors
  • Diet and metabolism studies
  • Obesity, Physical Activity, Diet
  • Mobile Health and mHealth Applications
  • Mechanical Circulatory Support Devices
  • Diet, Metabolism, and Disease
  • Adolescent and Pediatric Healthcare
  • Childhood Cancer Survivors' Quality of Life
  • Cardiac pacing and defibrillation studies
  • Advanced Control Systems Optimization
  • Control Systems and Identification
  • Metabolism, Diabetes, and Cancer
  • Healthcare Facilities Design and Sustainability
  • Renal and related cancers
  • Child Development and Digital Technology
  • Heart Rate Variability and Autonomic Control
  • Pancreatitis Pathology and Treatment
  • Diabetes Management and Education
  • Artificial Intelligence in Healthcare

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
2019-2025

Ospedale Regina Margherita
2023-2025

The University of Adelaide
2024

University of Bari Aldo Moro
2024

Hospital General Universitario de Elche
2024

Semnan University of Medical Sciences
2024

Cornell University
2024

University of Virginia
2024

University of Turin
2015-2024

Azienda Unità Sanitaria Locale Della Romagna
2024

OBJECTIVE The Pediatric Artificial Pancreas (PedArPan) project tested a children-specific version of the modular model predictive control (MMPC) algorithm in 5- to 9-year-old children during camp. RESEARCH DESIGN AND METHODS A total 30 children, 9-years old, with type 1 diabetes completed an outpatient, open-label, randomized, crossover trial. Three days artificial pancreas (AP) were compared three parent-managed sensor-augmented pump (SAP). RESULTS Overnight time-in-hypoglycemia was reduced...

10.2337/dc15-2815 article EN Diabetes Care 2016-03-25

To evaluate physicians' adjustments of insulin pump settings based on continuous glucose monitoring (CGM) for patients with type 1 diabetes and to compare these automated dose adjustments.A total 26 physicians from 16 centres in Europe, Israel South America participated the study. All were asked adjust dosing pump, CGM glucometer downloads 15 (mean age 16.2 ± 4.3 years, six female, mean glycated haemoglobin 8.3 0.9% [66.8 7.3 mmol/mol]) gathered over a 3-week period. Recommendations compared...

10.1111/dom.13408 article EN Diabetes Obesity and Metabolism 2018-06-09

Background: Glucose sensors consist of real-time continuous glucose monitoring (rtCGM) and intermittently scanned CGM (isCGM). Their clinical use has been widely increasing during the past 5 years. The aim this study is to evaluate percentage time in range (TIR) a large group children with type 1 diabetes (T1D) using nonautomated insulin delivery systems, real-world setting. Methods: An 11-center cross-sectional was conducted January-May 2019. Children T1D <18 years, all rtCGM or isCGM for...

10.1089/dia.2020.0031 article EN Diabetes Technology & Therapeutics 2020-02-19

Objective After a previous survey on the incidence of diabetic ketoacidosis (DKA) at onset type 1 diabetes in children 2013–2014 Italy, we aimed to verify possible decline DKA during national prevention campaign. Design Prospective observational study. Setting Multicentre study throughout Italy. Intervention National awareness campaign started November 2015 and held until December 2017. Patients During 2016 2017 collected data all patients aged 0–18 years with new-onset diabetes. Main...

10.1136/archdischild-2019-316903 article EN Archives of Disease in Childhood 2019-10-09

Aim/Hypothesis To compare the frequency of diabetic ketoacidosis (DKA) at diagnosis type 1 diabetes in Italy during COVID-19 pandemic 2020 with DKA 2017-2019. Methods Forty-seven pediatric centers caring for &amp;gt;90% young people recruited 4,237 newly diagnosed children between 2017 and a longitudinal study. Four subperiods were defined based on government-imposed containment measures COVID-19, frequencies severe compared same periods Results Overall, increased from 35.7% (95%CI,...

10.3389/fendo.2022.878634 article EN cc-by Frontiers in Endocrinology 2022-06-17

This document aims to clarify the position of scientific societies and associations people with diabetes regarding use Do It Yourself (DIY) software algorithms approved only by FDA, but not yet European/Italian regulatory agency. DIY systems are already used in Italy technical support is offered web community, important medical-legal issues. The describes most technologies briefly illustrates different algorithms; a paragraph has been inserted issues linked these particular focus on Italian...

10.30682/ildia2404a article EN il Diabete 2025-01-01

Neonatal diabetes (NDM) is a rare genetic disorder diagnosed in infants under six months of age, characterized by persistent hyperglycemia resulting from insufficient or absent insulin production. Unlike the more common forms diabetes, such as type 1 (T1D) and 2 (T2D), NDM predominantly caused monogenic mutations affecting ATP-sensitive potassium (K-ATP) channels pancreatic beta cells. The most involved are found KCNJ11 ABCC8 genes, which encode Kir6.2 SUR1 subunits K-ATP channel,...

10.3390/children12020219 article EN cc-by Children 2025-02-12

OBJECTIVE To explore the experiences of children with type 1 diabetes and their parents taking part in an artificial pancreas (AP) clinical trial during a 7-day summer camp. RESEARCH DESIGN AND METHODS A semistructured interview, composed 14 questions based on Technology Acceptance Model, was conducted at end trial. Participants also completed Diabetes Treatment Satisfaction Questionnaire (DTSQ, parent version) AP Questionnaire. RESULTS Thirty children, aged 5–9 years, study. content...

10.2337/dc16-1073 article EN Diabetes Care 2016-10-04

To evaluate the impact of a virtual educational camp (vEC) on glucose control in children and adolescents with type 1 diabetes using closed-loop (CLC) system.This was prospective multicentre study Tandem Basal-IQ system. Insulin pumps were upgraded to Control-IQ, their parents participated 3-day multidisciplinary vEC. Clinical data, metrics HbA1c evaluated over 12 weeks prior Control-IQ update after vEC.Forty-three (aged 7-16 years) families The median percentage time target range (70-180...

10.1111/dom.14491 article EN Diabetes Obesity and Metabolism 2021-07-06

There is conflicting evidence about the impact of COVID-19 pandemic on incidence type 1 diabetes. Here, we analysed long-term trends in diabetes Italian children and adolescents from 1989 to 2019 compared observed during with that estimated data.This was a population-based study using longitudinal data two registries mainland Italy. Trends January 31 December were Poisson segmented regression models.There significant increasing trend 3.6% per year [95% confidence interval (CI): 2.4-4.8]...

10.1111/dom.15024 article EN cc-by-nc-nd Diabetes Obesity and Metabolism 2023-02-22

Human endogenous retroviruses (HERVs) have been studied and proposed as relevant cofactors in several autoimmune diseases, including type 1 diabetes (T1D), though with controversial results no study at disease onset. In order to gather further information on the potential role of HERVs development T1D we assessed transcription levels pol genes HERV-H, HERV-K, HERV-W peripheral leucocytes from 37 children adolescents new-onset 50 age-matched control subjects. A PCR real time Taqman...

10.1080/08916934.2020.1777281 article EN Autoimmunity 2020-06-25
Riccardo Bonfanti Dario Iafusco Ivana Rabbone Giacomo Diedenhofen Carla Bizzarri and 95 more Patrizia Ippolita Patera Petra Reinstadler Francesco Costantino Valeria Calcaterra Lorenzo Iughetti Silvia Savastio Anna Favia Francesca Cardella Donatella Lo Presti Ylenia Girtler Sarah Rabbiosi Giuseppe d’Annunzio Angela Zanfardino Alessia Piscopo Francesca Casaburo Letizia Pintomalli Lucia Russo V. Grasso Nicola Minuto Mafalda Mucciolo Antonio Novelli Antonella Marucci Barbara Piccini Sonia Toni Francesca Silvestri Paola Carrera Andrea Rigamonti Giulio Frontino Michela Trada Davide Tinti Maurizio Delvecchio Novella Rapini Riccardo Schiaffini Corrado Mammì Fabrizio Barbetti _ _ _ _ Monica Aloe Simona Amadeo Claudia Arnaldi Marta Bassi Luciano Beccaria Marzia Benelli Giulia Maria Berioloi Enrica Bertelli Martina Biagioni A Bobbio Stefano Boccato Oriana Bologna Franco Bontempi Clara Bonura Giulia Bracciolini Claudia Brufani Patrizia Bruzzi Pietro Buono Valeria Calcaterra Roberta Cardani Giuliana Cardinale Alberto Casertano Maria Cristina Castiglione Vittoria Cauvin Valentino Cherubini F Chiarelli Giovanni Chiari Stefano Cianfarani Dante Cirillo Felice Citriniti Susanna Coccioli Anna Cogliardi Santino Confetto Giovanna Contreas Anna Corò Elisa Corsini Nicoletta Cresta Fiorella De Berardinis Valeria Donno Giampaolo De Filippo Rosaria De Marco Annalisa Deodati Elena Faleschini V. Fattorusso Valeria Favalli Barbara Felappi Lucia Ferrito G Fichera Franco Fontana Elena Fornari Roberto Franceschi Francesca Franco Adriana Franzese Anna Paola Frongia Alberto Gaiero Francesco Gallo L Gargantini Elisa Giani

Objective Transient neonatal diabetes mellitus (TNDM) is caused by activating mutations in ABCC8 and KCNJ11 genes (K ATP /TNDM) or chromosome 6q24 abnormalities (6q24/TNDM). We wanted to assess whether these different genetic aetiologies result distinct clinical features. Design Retrospective analysis of the Italian data set patients with TNDM. Methods Clinical features treatment 22 K /TNDM 12 6q24/TNDM were compared. Results Fourteen probands had a carrier parent abnormal glucose values,...

10.1530/eje-20-1030 article EN European Journal of Endocrinology 2021-02-19

Despite advances in the management of type 1 diabetes (T1D), there is an increasing incidence skin reactions related to devices such as patch pumps and glucose sensors. Aim present study was assess prevalence dermatological complications pediatric patients with T1D using technological devices.Online survey regarding use and/or sensors administered families children adolescents (0-17 years) T1D. Data were collected on demographic characteristics, duration diabetes, clinical features if...

10.1177/1932296820947072 article EN Journal of Diabetes Science and Technology 2020-08-06

To assess the optimal setting of predictive low glucose management (PLGM) algorithm for preventing exercise-induced hypoglycemia in adolescents with type 1 diabetes.Thirty-four adolescents, 15 to 20 years, wearing PLGM system, were followed during 3 days exercise a diabetes camp. threshold was set at 70 mg/dL between 8 am and 10 pm 90 Adolescents divided into group A B, mg/dL, respectively, exercise. Time spent AUC time slots pm, 4 11 am, compared groups by Wilcoxon rank sum test.We analyzed...

10.1111/pedi.12792 article EN Pediatric Diabetes 2018-10-31
Coming Soon ...